Literature DB >> 17088336

Bronchoscopy following diagnosis with cystic fibrosis.

Tom N Hilliard1, Seema Sukhani, Jacqueline Francis, Neil Madden, Mark Rosenthal, Ian Balfour-Lynn, Andrew Bush, Jane C Davies.   

Abstract

We recently changed our practice to perform bronchoscopy following diagnosis with cystic fibrosis. On a retrospective review of 25 children, Pseudomonas aeruginosa was detected in bronchoalveolar lavage for the first time in five children (20%) and Staphylococcus aureus in four (16%). Lavage culture was positive in eight of 18 children without respiratory symptoms. This highlights the potential of bronchoscopy following diagnosis, even in asymptomatic children.

Entities:  

Mesh:

Year:  2006        PMID: 17088336      PMCID: PMC2083238          DOI: 10.1136/adc.2006.105825

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.

Authors:  David S Armstrong; Sarah M Hook; Kris M Jamsen; Gillian M Nixon; Rosemary Carzino; John B Carlin; Colin F Robertson; Keith Grimwood
Journal:  Pediatr Pulmonol       Date:  2005-12

2.  Airway function in infants newly diagnosed with cystic fibrosis.

Authors:  S C Ranganathan; C Dezateux; A Bush; S B Carr; R A Castle; S Madge; J Price; J Stroobant; A Wade; C Wallis; J Stocks
Journal:  Lancet       Date:  2001-12-08       Impact factor: 79.321

Review 3.  Pathophysiology and management of pulmonary infections in cystic fibrosis.

Authors:  Ronald L Gibson; Jane L Burns; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2003-10-15       Impact factor: 21.405

4.  Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients.

Authors:  B W Ramsey; K R Wentz; A L Smith; M Richardson; J Williams-Warren; D L Hedges; R Gibson; G J Redding; K Lent; K Harris
Journal:  Am Rev Respir Dis       Date:  1991-08
  4 in total
  9 in total

1.  What and when to collect from infants with cystic fibrosis.

Authors:  Iolo Doull
Journal:  Arch Dis Child       Date:  2007-10       Impact factor: 3.791

2.  Flexible fiberoptic bronchoscopy in Greek children.

Authors:  F Kirvassilis; D Gidaris; M Ventouri; A Zampouri; M Mylona; A Keramidiotis; Th Kontakiotis; I Tsanakas
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

3.  Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening.

Authors:  Lacrecia J Britton; Gabriela R Oates; Robert A Oster; Staci T Self; Robert B Troxler; Wynton C Hoover; Hector H Gutierrez; William T Harris
Journal:  Pediatr Pulmonol       Date:  2016-08-24

4.  The Th17 pathway in cystic fibrosis lung disease.

Authors:  Hui-Leng Tan; Nicolas Regamey; Sarah Brown; Andrew Bush; Clare M Lloyd; Jane C Davies
Journal:  Am J Respir Crit Care Med       Date:  2011-04-07       Impact factor: 21.405

Review 5.  Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Authors:  Simon C Langton Hewer; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2017-04-25

6.  2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung.

Authors:  Amy J Scott-Thomas; Mona Syhre; Philip K Pattemore; Michael Epton; Richard Laing; John Pearson; Stephen T Chambers
Journal:  BMC Pulm Med       Date:  2010-11-07       Impact factor: 3.317

7.  Safety of research bronchoscopy with BAL in stable adult patients with cystic fibrosis.

Authors:  Daniel Aridgides; John Dessaint; Graham Atkins; James Carroll; Alix Ashare
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

Review 8.  Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.

Authors:  Kamini Jain; Claire Wainwright; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2018-09-17

9.  Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.

Authors:  Theresa A Laguna; Brandie D Wagner; Cynthia B Williams; Mark J Stevens; Charles E Robertson; Cole W Welchlin; Catherine E Moen; Edith T Zemanick; Jonathan K Harris
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.